| This week's sponsor is Premier Research. | | | Immunotherapy: Unleashing the Body's Potential to Fight Cancer
The immune system's role in fighting cancer becomes clearer every day, and the therapeutic implications are enormous. Discover promising new approaches to immunotherapy in our new white paper.
Premier Research. It's what we do. Best. |
Featured Story | | | Tuesday, June 27, 2017 Hit by trial setbacks and failures that have blighted the entire class, Merck is mulling whether to file its cholesteryl ester transfer protein (CETP) medication anacetrapib after posting some surprising positive topline data from the Reveal test. |
|
|
| This week's sponsor is Sensors Expo & Conference 2017. | | | |
Top Stories Tuesday, June 27, 2017 Controversial billionaire biotech entrepreneur Patrick Soon-Shiong and his outfit NantCell say it will acquire Altor Bioscience for two bucks a share, plus a weighted CVR. Tuesday, June 27, 2017 It’s another hard luck story for Xenon and partner Teva’s experimental pain drug TV-45070 after missing a full set of endpoints in patients with pain following shingles. Monday, June 26, 2017 Neoantigen-based cancer vaccines represent new, truly personalized therapeutic approaches to treating cancer. Tuesday, June 27, 2017 The third BioGeneration Ventures Fund has gone over its €50 million target and hit €66 million ($74 million) as it attracts new investors. Tuesday, June 27, 2017 New York City's bid to become a life sciences hotspot took another step forward this week with the help of a $5 million grant from the mayor's office. Tuesday, June 27, 2017 Preclinical startup Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders, including its lead candidate for Huntington’s disease. Monday, June 26, 2017 Low-density lipoprotein is commonly called “bad cholesterol” because it builds up along the walls of the arteries, forming plaques that can cause deadly blockages. A new finding by scientists at NYU shows how a key player in that inflammatory process switches roles, becoming a healing influence instead. Tuesday, June 27, 2017 Digital diabetes management player Glooko has been on a roll and is showing no signs of stopping. The company has picked up $35 million to further develop its technology and expand in a number of geographic regions. Monday, June 26, 2017 Last June, a key CDC vaccines committee stiff-armed AstraZeneca's nasal influenza vaccine based on worries about its effectiveness. Despite the company's efforts to fix things since then, the committee once again recommended that doctors eschew FluMist for the upcoming flu season. | This week's sponsor is J.P. Morgan Private Bank. | | | How Your Assets Are Structured Can Have Long-Term Implications On Your Wealth
As a founder or executive of a healthcare business, it's crucial your assets are titled properly. J.P. Morgan Private Bank knows how to protect your assets and preserve your wealth. Download this article on asset ownership to learn more. |
| | | It's name-change day, as RaNA Therapeutics has relaunched as Translate Bio, coming after its recent Shire deal. Statement Cancer company Lion Biotechnologies has changed its name to Iovance Biotherapeutics with a new Nasdaq ticker symbol "IOVA" to boot. Release Hoping to compete with Big Pharma rivals, Alder has posted new positive phase 3 data for eptinezumab in preventing frequent episodic migraine. Statement | |
|
Resources Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Envigo Discover the factors that contribute to differential radiation sensitivity between the Rag2 and SCID models. Presented by: Veeva Hear three innovative leaders explain how regulatory can “go digital” in their operations by leveraging the data-handling capabilities in their RIM systems. Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA |
